COMMON WARTS
Clinical trials for COMMON WARTS explained in plain language.
Never miss a new study
Get alerted when new COMMON WARTS trials appear
Sign up with your email to follow new studies for COMMON WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a medicated gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel safely clears all warts by day 84.
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 06:33 UTC
-
New gel shows promise for stubborn warts in extended trial
Disease control Recruiting nowThis study follows people who previously took part in a wart treatment study (COVE-2 or COVE-3) to see if YCANTH gel is safe and works over a longer period. Participants with remaining warts can get up to 4 more treatments, applied every 21 days. The goal is to clear all warts, a…
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Pain-free wart cream for kids shows promise in new study
Symptom relief Recruiting nowThis study tests a cream made of two medicines (5-fluorouracil and calcipotriol) on children aged 4 to 18 with warts on their hands or feet. The goal is to see if the cream can clear warts without the pain of common treatments like freezing. Sixty children will use either the act…
Matched conditions: COMMON WARTS
Phase: NA • Sponsor: Mazandaran University of Medical Sciences • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC